preloader-icon-85

Your brain is your most precious asset, protect it with early detection

Our Approach

Welcome to Talia, a groundbreaking product that’s being developed by Basil Health to detect Alzheimer’s disease in its early stages using EEG and P300 technology. Our approach to early detection of Alzheimer’s is a game changer in the field of cognitive health, and we are proud to be at the forefront of this revolution

How We Use EEG and P300 to Detect Alzheimer's in the Early Stage

We use our innovative technology to monitor brain activity and identify specific biomarkers associated with Alzheimer’s disease 

Our patented algorithm analyzes the data to detect any abnormalities in the brain waves, allowing us to identify Alzheimer’s disease in its early stages, before symptoms become apparent 

Why Talia?

Traditional methods of detecting Alzheimer's, such as cognitive tests and brain scans, can be time-consuming, costly, and often unreliable. 

In contrast, Talia's science based approach is quick, painless, and highly accurate, providing early detection of Alzheimer's disease with minimal inconvenience to patients. 

The Benefits of Early Detection of Alzheimer's Disease

– Early diagnosis can lead to earlier treatment, which may slow or even halt the progression of the disease.

– It also provides individuals with the opportunity to plan for the future, both financially and emotionally, and to make informed decisions about their care.

About

At Basil Health, we are committed to advancing healthcare through innovation and cutting-edge technology. We invite you to explore our solutions and discover how we can help you achieve your healthcare and research goals.

Products

Follow Us

Copyright, Basil Health